C.F.R.
»
Title 21
» CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER A—GENERAL › PART 7—ENFORCEMENT POLICY › Subpart C—Recalls (Including Product Corrections)—Guidance on Policy, Procedures, and Industry Responsibilities
(a) Recall is an effective method of removing or correcting consumer products that are in violation of laws administered by the Food and Drug Administration. Recall is a voluntary action that takes place because manufacturers and distributors carry out their responsibility to protect the public health and well-being from products that present a risk of injury or gross deception or are otherwise defective. This section and §§ 7.41 through 7.59 recognize the voluntary nature of recall by providing guidance so that responsible firms may effectively discharge their recall responsibilities. These sections also recognize that recall is an alternative to a Food and Drug Administration-initiated court action for removing or correcting violative, distributed products by setting forth specific recall procedures for the Food and Drug Administration to monitor recalls and assess the adequacy of a firm's efforts in recall.
(b) Recall may be undertaken voluntarily and at any time by manufacturers and distributors, or at the request of the Food and Drug Administration. A request by the Food and Drug Administration that a firm recall a product is reserved for urgent situations and is to be directed to the firm that has primary responsibility for the manufacture and marketing of the product that is to be recalled.
(c) Recall is generally more appropriate and affords better protection for consumers than seizure, when many lots of product have been widely distributed. Seizure, multiple seizure, or other court action is indicated when a firm refuses to undertake a recall requested by the Food and Drug Administration, or where the agency has reason to believe that a recall would not be effective, determines that a recall is ineffective, or discovers that a violation is continuing.
[43 FR 26218, June 16, 1978, as amended at 65 FR 56476, Sept. 19, 2000]
Notes of Decisions
Cited in
18
cases (
2 in the last 5 years), 1981–2024 · leading case:
Gross v. Stryker Corp., 858 F. Supp. 2d 466 (W.D. Pa. 2012).
Gross v. Stryker Corp., 858 F. Supp. 2d 466 (W.D. Pa. 2012).
· cites it 2× “” 21 C.F.R. § 7.40 . Furthermore, a manufacturer may initiate a recall “because it believes the product to be violative.”
In Re Medtronic, Inc. Sprint Fidelis Leads Prods. Liab. Litig., 592 F. Supp. 2d 1147 (D. Minnesota 2009).
“21 C.F.R. § 7.40 (a). Yet, there would be no reason to invalidate the device's PMA — if the assembly error were corrected, then the device could (and would) be manufactured according to the FDA-approved PMA specifications.”
Jones v. Conagra Foods, Inc., 912 F. Supp. 2d 889 (N.D. Cal. 2012).
“§ 332 ; 21 C.F.R. § 7.40 . In 1990, Congress passed the NLEA to specifically address certain food and beverage labeling requirements, such as requiring the identification of artificial flavors on the label, 21 U.”
Lockwood v. Conagra Foods, Inc., 597 F. Supp. 2d 1028 (N.D. Cal. 2009).
“The purpose of the NLEA was to “ ‘clarify and to strengthen [FDA’s] authority to require nutrition labeling on foods, and to establish the circumstances under which claims may be made about the nutrients in foods.”
Steven Recht v. Patrick Morrisey, 32 F.4th 398 (4th Cir. 2022).
“or at the request of the [FDA],” 21 C.F.R. § 7.40 (a)–(b), plaintiffs conclude that the Act bans the use of the word “recall” in this situation.”
Banfi Prods. Corp. v. United States, 40 Fed. Cl. 107 (Fed. Cl. 1997).
· cites it 2× “21 C.F.R. § 7.40 . According to the language of the final rule, the regulations were intended as “guidelines.”
Clark v. Actavis Grp. HF, 567 F. Supp. 2d 711 (D.N.J. 2008).
· cites it 3× “2d at 432 (citing 21 C.F.R. § 7.40 (a)). “These regulations set forth specific recall procedures whereby the FDA assumes control over monitoring recalls and assesses the adequacy of a firm’s efforts in undertaking the recall.”
Wash. Cnty. Health Care Auth., Inc. v. Baxter Int'l Inc., 328 F. Supp. 3d 824 (E.D. Ill. 2018).
“§ 331 (a) (prohibiting "the introduction or delivery for introduction into interstate commerce of any food, drug, device, tobacco product, or cosmetic that is adulterated or misbranded"); see also 21 C.F.R. § 7.40 (noting that "recall is an alternative to a Food and Drug…”
United States v. Superpharm Corp., 530 F. Supp. 408 (E.D.N.Y 1981).
· cites it 3× “While there are provisions in the FDA regulations which provide for recalls, recalls cannot be ordered by the FDA, see 21 CFR § 7.40 (a), as they are usually undertaken voluntarily, 21 CFR § 7.”
Holk v. Snapple Beverage Corp., 574 F. Supp. 2d 447 (D.N.J. 2008).
· cites it 2× “§ 332 ; 21 C.F.R. § 7.40 . The FDA has promulgated comprehensive regulations pursuant to its authority under the FFDCA.”
— 21 C.F.R. § 7.40(a) — 1 case
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.